# Fischer Medical Ventures Ltd (FISCHER) > Exchange: NSE | Sector: Healthcare | ISIN: ## Price Current Price: ₹37.69 Day Change: +3.32% 52W High: ₹124.2 52W Low: ₹32.09 Market Cap: ₹2,284 Cr ## Valuation P/E: 59.15 P/B: 6.27 EPS: ₹0.59 Book Value: ₹5.57 Dividend Yield: 0% ## Returns 1Y Return: -37.96% ## Profitability ROE: 0% ROCE: 6.4% Debt/Equity: 0.1 Revenue Growth: 760.5% Profit Growth: 0% EBITDA Margin: 16.59% Operating Margin: 20.57% ## About Fischer Medical Ventures Ltd is a Medical Devices company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place. Sector: Healthcare Industry: Medical Devices Sub Industry: Unknown ## Business Model Overview: Fischer Medical Ventures Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Medical Devices. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Healthcare. Source: Derived from stock data Revenue Streams: - Domestic formulations - Exports and regulated markets - Specialty or institutional sales Operating Model: - Develops, manufactures, distributes, or services healthcare products across regulated channels. - Approvals, product mix, compliance quality, and R&D productivity shape growth. Recent Context: - Announcement: Announcement under Regulation 30 (LODR)-Monitoring Agency Report - Announcement: Announcement under Regulation 30 (LODR)-Newspaper Publication - BSE Filing: Announcement under Regulation 30 (LODR)-Monitoring Agency Report ## Access Current tier: anonymous More history: Register free to see 2 more years. ## Data Freshness Quote Updated: 2026-05-25T16:00:08.172Z Price History Updated: 2026-05-25T05:31:34.535Z Latest Price History Date: 2026-05-24 Technicals Updated: 2026-05-25T05:31:34.535Z Quant Updated: 2026-05-25T05:31:34.535Z Sentiment Updated: 2026-05-25T05:31:34.535Z Financials Status: current Financials Updated: 2026-05-19T01:30:08.248Z Financials Last Attempt: 2026-05-19T01:30:08.248Z Financials Provider Tried: yahoo Latest P&L Period: FY25 Latest Balance Sheet Period: FY25 Latest Cash Flow Period: FY25 ## P&L (FY25) Revenue: ₹110.7 Cr Operating Profit: ₹3.06 Cr (OPM 2.76%) Net Profit: ₹1.21 Cr Tax: ₹1.01 Cr ## Annual P&L History FY25: Rev ₹110.7Cr | PAT ₹1.21Cr | OPM 2.76% FY24: Rev ₹20.98Cr | PAT ₹1.84Cr | OPM 8.01% FY23: Rev ₹0.18Cr | PAT ₹-0.04Cr | OPM 11.11% ## Balance Sheet (FY25) Total Assets: ₹457.37 Cr Total Liabilities: ₹119.5 Cr Borrowings: ₹85.37 Cr Cash: ₹104.26 Cr ## Shareholding undefined: undefined% undefined: undefined% undefined: undefined% undefined: undefined% undefined: undefined% undefined: undefined% undefined: undefined% undefined: undefined% undefined: undefined% undefined: undefined% undefined: undefined% ## Board - Ravindran Govindan LLB, MD & Chairman - Vivek Balasubramanian, Chief Financial Officer - Shankar Varadharajan, Chief Operating Officer - Balaji Gandla, Company Secretary & Compliance Officer - Sannasi Thirupathi, Head of Human Resources --- Source: rupiya.io/stocks/fischer Disclaimer: For research and education only. Not investment advice.